Literature DB >> 10191223

An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

A Holmes1, R Nolan, R Taylor, R Finley, M Riley, R Z Jiang, S Steinbach, R Goldstein.   

Abstract

Burkholderia cepacia is an important pathogen in cystic fibrosis (CF) and an infrequent cause of nosocomial infection in non-CF patients. This report describes a large hospital outbreak that appeared to involve both patient groups, a previously unrecognized phenomenon. Ribotype restriction fragment length polymorphism (RFLP) profiles and pulsed-field gel electrophoresis-resolved macrochromosomal RFLPs were analyzed, a ribotype-based phylogenic tree was constructed, and case-control and cohort studies were performed. A single dominant clone was found in both CF and non-CF groups. Phylogenic analysis suggests that it has evolved independently and that such highly transmissible strains can emerge rapidly and randomly. Acquisition risk in the CF patients was linked to hospitalization (odds ratio=5.47, P=.0158, confidence interval=1. 28-26.86) and was associated with significantly increased mortality rates. Infection control policies must now consider this threat of transmission between non-CF and CF patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191223      PMCID: PMC3325287          DOI: 10.1086/314699

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak.

Authors:  D J Anderson; J S Kuhns; M L Vasil; D N Gerding; E N Janoff
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

Authors:  C S Rabkin; W R Jarvis; R L Anderson; J Govan; J Klinger; J LiPuma; W J Martone; H Monteil; C Richard; S Shigeta
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

3.  Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

Authors:  J J LiPuma; J E Mortensen; S E Dasen; T D Edlind; D V Schidlow; J L Burns; T L Stull
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

4.  Identifying the killer in cystic fibrosis.

Authors:  J E Hearst; K E Elliott
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

Review 5.  Burkholderia cepacia: medical, taxonomic and ecological issues.

Authors:  J R Govan; J E Hughes; P Vandamme
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

6.  Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Authors:  L A Carson; O C Tablan; L B Cusick; W R Jarvis; M S Favero; L A Bland
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

Review 7.  Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.

Authors:  D A Goldmann; J D Klinger
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

8.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

9.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

Review 10.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more
  35 in total

Review 1.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Health service careers for people with cystic fibrosis.

Authors:  Sarah Walters
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J Lipuma; Peter Vandamme; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Intramural bladder-wall abscess: a late complication arising after a urethrocystoscopy?

Authors:  Hagen Loertzer; Sven Olaf Höhne; Rainer Finke; Paolo Fornara
Journal:  Pediatr Surg Int       Date:  2005-01-12       Impact factor: 1.827

5.  Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation.

Authors:  Ana S Ferreira; Jorge H Leitão; Sílvia A Sousa; Ana M Cosme; Isabel Sá-Correia; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2006-11-17       Impact factor: 4.792

6.  Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex.

Authors:  Karlene H Lynch; Jonathan J Dennis
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

7.  Molecular genetic basis of ribotyping.

Authors:  Valérie Bouchet; Heather Huot; Richard Goldstein
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Species abundance and diversity of Burkholderia cepacia complex in the environment.

Authors:  Alban Ramette; John J LiPuma; James M Tiedje
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.

Authors:  Mónica V Cunha; Sílvia A Sousa; Jorge H Leitão; Leonilde M Moreira; Paula A Videira; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Lyn O'Reilly; Niki Foster; Adele Clair; Judy Sampson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.